Concept of Pharmacoeconomics and Assessment Techniques Flashcards
Define pharmacoeconomics and its importance in healthcare
pharmacoeconomics= measure and compares costs and consequence of pharmaceutical products and services
importance = form economic relationship b/t research production distribution storage pricing and further use by people
Outline the main techniques used in pharmacoeconomics
cost minimisation, cost effectiveness, cost benefit and cost utility analysis.
pharmacoeconomic analyses are available: COI analysis, cost analyses, CEA, CUA, CMA, CBA
Discuss how clinical effectiveness is assessed.
Approach: Multifaceted assessment.
- Mechanisms: Clinical audit, outcome measurement, quality improvement, service evaluation, benchmarking.
- Contribution: Offers a comprehensive real-world view of intervention effectiveness.
- Examples: Clinical audit ensures standards, outcome measurement quantifies impact, quality improvement refines practices, benchmarking enables industry comparisons.
Discuss how cost effectiveness is assessed.
Analysis Method: Compute cost-effectiveness ratio.
- Formula: Net cost divided by changes in health outcomes.
- Examples: Cost per case prevented, cost per death averted.
(Note: Negative net costs indicate cost savings.) - Significance: Provides nuanced understanding of economic implications for informed healthcare resource allocation decisions.
Emphasize the importance of maintaining a robust knowledge base for future success
- Crucial Foundation: A robust knowledge base serves as the foundational pillar for success in any field.
- Continuous Evolution: Given the dynamic nature of disciplines like pharmacoeconomics, maintaining knowledge is crucial for staying abreast of evolving concepts, methodologies, and best practices.
- Informed decision making
- professional growth
- competitive edge
- enhanced problem solving
- contribution to innovation
Explain the role of pharmacoeconomics in drug regulation.
Plays an integral role in internal decision-making. Its early integration enhances R&D resource efficiency, laying a solid foundation for effective communication of product value to external decision-makers
Core issues related to the integration of pharmacoeconomic considerations in regulatory decisions
- Balancing Efficacy and Cost
- Methodological standardisation
- Data quality analysis
- patient access and affordability
- uncertencies in economic models
- Societal Impact and Budget Constraints
- Communication Challenges
- post market surveillance
Impact of Pharmacoeconomics on Drug Approval Processes
Decision-Making Influence:
Resource Optimization:
Regulatory Submissions:
Payer Acceptance and Reimbursement:
Market Access and Commercial Success:
Health Technology Assessments (HTAs):
Economic Value Proposition:
Post-Approval Commitments:
Patient Access and Affordability:
Competitive Landscape:
Global Regulatory Expectations:
Long-Term Value Assessment: